We are live on ! Find out more
NMRD

Nemaura Medical, Inc. Common Stock
NMRD

Delisted

NMRD was delisted on the 4th of January, 2024.

Back to rankings

16 hedge funds and large institutions have $2.88M invested in Nemaura Medical, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

107% more capital invested

Capital invested by funds: $1.39M → $2.88M (+$1.49M)

0% more funds holding

Funds holding: 16 → 16 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

Holders
16
Holders Change
–
Holders Change %
0%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
1
Closed
2
Calls
$11K
Puts
–
Net Calls
+$11K
Net Calls Change
+$11K

Top Buyers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$3.21M
2
State Street
State Street
Massachusetts
+$23.3K
3
Northern Trust
Northern Trust
Illinois
+$11.4K
4
Simplex Trading
Simplex Trading
Illinois
+$4.16K
5
TRCT
Tower Research Capital (TRC)
New York
+$1.52K

Top Sellers

Rank Fund Capital Flow
1
AIP
ARS Investment Partners
New York
-$134K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$36.8K
3
UBS Group
UBS Group
Switzerland
-$6.55K
Name Holding Trade Value Shares
Change 		Change in
Stake
Alyeska Investment Group
1
Alyeska Investment Group
Illinois
$2.22M +$3.21M +2,483,271 New
TM
2
Tiger Management
New York
$336K – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$117K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$94.4K – – –
State Street
5
State Street
Massachusetts
$47K +$23.3K +18,042 +51%
BlackRock
6
BlackRock
New York
$29.3K +$1.16K +900 +3%
Northern Trust
7
Northern Trust
Illinois
$23.9K +$11.4K +8,786 +49%
TRCT
8
Tower Research Capital (TRC)
New York
$4K +$1.52K +1,175 +34%
Wells Fargo
9
Wells Fargo
California
$3.72K +$1.34K +1,035 +33%
Simplex Trading
10
Simplex Trading
Illinois
$2K +$4.16K +3,219 New
FDCDDQ
11
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.75K – – –
NA
12
NewEdge Advisors
Louisiana
$322 – – –
Morgan Stanley
13
Morgan Stanley
New York
$90 – – –
UBS Group
14
UBS Group
Switzerland
$76 -$6.55K -5,063 -98%
AIP
15
ARS Investment Partners
New York
– -$134K -78,269 Closed
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
– -$36.8K -21,636 Closed

NMRD Hedge Fund Activity: Q1 2023 in Review

16 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Nemaura Medical, Inc. Common Stock (NMRD) for Q1 2023, worth a combined $2.88M — up 107% from $1.39M a quarter earlier.

Fund positioning in NMRD was balanced in Q1 2023: 2 funds opened new positions, 2 closed out, 5 added to existing stakes and 1 trimmed.

The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $3.21M. The largest seller was ARS Investment Partners, exiting entirely with an estimated $134K sold.

  • 16 institutional investors held Nemaura Medical, Inc. Common Stock (NMRD) as of Q1 2023, unchanged from Q4 2022.
  • Funds reported $2.88M of Nemaura Medical, Inc. Common Stock stock for Q1 2023, up 107% quarter-over-quarter.
  • 2 funds opened new Nemaura Medical, Inc. Common Stock positions in Q1 2023 and 2 closed out, a net change of 0 holders.
  • The largest Nemaura Medical, Inc. Common Stock buyer in Q1 2023 was Alyeska Investment Group, an estimated $3.21M added.
  • The largest Nemaura Medical, Inc. Common Stock seller in Q1 2023 was ARS Investment Partners, an estimated $134K sold.

Based on aggregated 13F filings for Q1 2023.